As of December 2024, VistaGen Therapeutics has a market cap of $67.02M. This makes VistaGen Therapeutics the world's 4106th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $143.84M | 3.56% |
2023 | $138.90M | 66.34% |
2022 | $83.50M | -94.72% |
2021 | $1.58B | 0.52% |
2020 | $1.57B | 181.28% |
2019 | $559.13M | -54.02% |
2018 | $1.22B | 34.72% |
2017 | $902.62M | -70.15% |
2016 | $3.02B | -62.09% |
2015 | $7.98B | 15.76% |
2014 | $6.89B | 1.19% |
2013 | $6.81B | -42.47% |
2012 | $11.84B | -76.07% |
2011 | $49.45B | - |